Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 5/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4556319 | 0.83 | SCD (0.35) | SCDCYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL13930599 | 0.81 | GRM5 (0.37) | SCDCYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL4449297 | 0.76 | GRM5 (0.36) | SCDFFAR4 | |
| SCHEMBL31535480 | 0.69 | FFAR4 (0.41) | FFAR4ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL4555697 | 0.66 | CALML3 (0.45) | CYP3A4CYP2C9CYP2C19FFAR4 | |
| SCHEMBL3832525 | 0.64 | OPRL1 (0.48) | CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL13930468 | 0.64 | DRD2 (0.41) | SCDCYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL4566242 | 0.59 | CYP3A4 (0.42) | SCDCYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL8976354 | 0.58 | HTR2C (0.33) | — | |
| SCHEMBL3222795 | 0.57 | SCD (0.48) | SCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009037542-A2 | SPIROCYCLIC COMPOUNDS AS STEAROYL COA DESATURASE INHIBITORS | GLENMARK PHARMACEUTICALS, S.A. (US) | 2009-03-26 | — | — | WO | claimed |